Department of Medicine, University of Montreal, CRCHUM, Quebec, Canada.
Department of Physiology, College of Graduate Studies, Midwestern University, Glendale, AZ, United States of America.
PLoS One. 2019 Jul 3;14(7):e0219205. doi: 10.1371/journal.pone.0219205. eCollection 2019.
In the rat, oxytocin (OT) produces dose-dependent diuretic and natriuretic responses. Post-translational enzymatic conversion of the OT biosynthetic precursor forms both mature and C-terminally extended peptides. The plasma concentrations of these C-terminally extended peptides (OT-G; OT-GK and OT-GKR) are elevated in newborns and pregnant rats. Intravenous injection of OT-GKR to rats inhibits diuresis, whereas injection of amidated OT stimulates diuresis. Since OT and OT-GKR show different effects on the urine flow, we investigated whether OT-GKR modulates renal action by inhibition of the arginine-vasopressin (AVP) receptor V2 (V2R), the receptor involved in renal water reabsorption. Experiments were carried out in the 8-week-old Wistar rats receiving intravenous (iv) injections of vehicle, OT, OT-GKR or OT+OT-GKR combination. OT (10 μmol/kg) increased urine outflow by 40% (P<0.01) and sodium excretion by 47% (P<0.01). Treatment with OT-GKR (10 μmol/kg) decreased diuresis by 50% (P<0.001), decreased sodium excretion by 50% (P<0.05) and lowered potassium by 42% (P<0.05). OT antagonist (OTA) reduced diuresis and natriuresis exerted by OT, whereas the anti-diuretic effect of OT-GKR was unaffected by OTA. The treatment with V2R antagonist (V2A) in the presence and absence of OT induced diuresis, sodium and potassium outflow. V2A in the presence of OT-GKR only partially increased diuresis and natriuresis. Autoradiography and molecular docking analysis showed potent binding of OT-GKR to V2R. Finally, the release of cAMP from CHO cells overexpressing V2 receptor was induced by low concentration of AVP (EC50:4.2e-011), at higher concentrations of OT (EC50:3.2e-010) and by the highest concentrations of OT-GKR (EC50:1.1e-006). OT-GKR potentiated cAMP release when combined with AVP, but blocked cAMP release when combined with OT. These results suggest that OT-GKR by competing for the OT renal receptor (OTR) and binding to V2R in the kidney, induces anti-diuretic, anti-natriuretic, and anti-kaliuretic effects.
在大鼠中,催产素(OT)产生剂量依赖性的利尿和利钠反应。OT 生物合成前体的翻译后酶转化形成成熟和 C 末端延伸的肽。这些 C 末端延伸肽(OT-G;OT-GK 和 OT-GKR)的血浆浓度在新生儿和妊娠大鼠中升高。OT-GKR 静脉注射到大鼠中抑制利尿,而酰胺化 OT 注射刺激利尿。由于 OT 和 OT-GKR 对尿量有不同的影响,我们研究了 OT-GKR 是否通过抑制参与肾水重吸收的精氨酸血管加压素(AVP)受体 V2(V2R)来调节肾脏作用。实验在接受静脉(iv)注射载体、OT、OT-GKR 或 OT+OT-GKR 组合的 8 周龄 Wistar 大鼠中进行。OT(10 μmol/kg)使尿量增加 40%(P<0.01),钠排泄增加 47%(P<0.01)。OT-GKR(10 μmol/kg)处理使利尿减少 50%(P<0.001),钠排泄减少 50%(P<0.05),钾排泄减少 42%(P<0.05)。OT 拮抗剂(OTA)降低了 OT 引起的利尿和利钠作用,而 OT-GKR 的抗利尿作用不受 OTA 影响。在存在和不存在 OT 的情况下,V2R 拮抗剂(V2A)的治疗诱导了利尿、钠和钾外流。OT-GKR 存在时,V2A 仅部分增加利尿和利钠作用。放射自显影和分子对接分析显示 OT-GKR 与 V2R 具有强结合。最后,低浓度 AVP(EC50:4.2e-011)诱导过表达 V2 受体的 CHO 细胞中环磷酸腺苷(cAMP)的释放,高浓度 OT(EC50:3.2e-010)和最高浓度 OT-GKR(EC50:1.1e-006)。OT-GKR 与 AVP 结合时增强 cAMP 释放,但与 OT 结合时阻断 cAMP 释放。这些结果表明,OT-GKR 通过与肾脏中的 OT 肾受体(OTR)竞争并与 V2R 结合,诱导抗利尿、抗利钠和抗钾作用。